United Therapeutics Corp. (UTHR)

$ 470.51
   
  • Change Today:
    $-10.01
  • 52 Week High: $517.13
  • 52 Week Low: $274.70
  • Currency: US Dollars
  • Shares Issued: 43.56m
  • Volume: 110,213
  • Market Cap: $20,497m
  • RiskGrade: 132
  • Beta: 0.00

Latest ShareCast News

GlaxoSmithKline reportedly running the ruler over US rival

By Alexander Bueso

Date: Friday 04 Aug 2017

(ShareCast News) - GlaxoSmithKline may be studying a possible bid for US rival United Therapeutics, The Evening Standard reported citing City sources.

UTHR ShareCast News

No recent information was found.

UTHR Newspaper Links

Contracting 06-Dec-2007 Washington Post
United Therapeutics Shares Soar on FDA Report 02-Nov-2007 Washington Post
Study Raises Questions For United Therapeutics 27-Feb-2007 Washington Post
United Therapeutics Says Profit Plummets 70 Perc... 03-May-2006 Washington Post
United Therapeutics' Profit Surges 22-Feb-2006 Washington Post

UTHR Tips & Analysis

Test of Insomnia Drug Bolsters Vanda's Plan 16-Nov-2006 Washington Post
2005 Compensation For Top-Earning Executives Gre... 10-Jul-2006 Washington Post

UTHR News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

UTHR Market Data

Currency US Dollars
Share Price $ 470.51
Change Today $ -10.01
% Change -2.08 %
52 Week High $517.13
52 Week Low $274.70
Volume 110,213
Shares Issued 43.56m
Market Cap $20,497m
Beta 0.00
RiskGrade 132

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 15
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 20-Feb-2026

Time Volume / Share Price
13:19 50 @ $470.51
13:16 40 @ $470.16
13:16 100 @ $469.66
13:16 53 @ $469.65
13:16 40 @ $469.65

Top of Page